Design, Synthesis, and Anticancer Activity Evaluation of N′-Arylidenehydrazides of Isopimaric Acid
摘要
A series of N′-aryldenehydrazide derivatives from isopimaric acid were designed, synthesized, and evaluated for their anticancer activities. Some synthesized compounds showed stronger anticancer activity than the positive control drug 5-fluorouracil (5-FU). Compound 3c, with a hydroxyl and a methoxyl in the benzene, exhibited the strongest cytotoxicity against human malignant melanoma cells (A375) and ovarian carcinoma cells (ES-2), with IC50 values of 9.54 and 5.43 μM, respectively. It also demonstrated reduced toxicity to normal human hepatocytes (L-O2), making it the most promising anticancer candidate. Structure–activity relationship studies revealed that the introduction of the hydroxyl group into the benzene ring is beneficial to improve the antitumor activity.